Skip to content
Head to head

Henry Schein vs McKesson

Side-by-side on the measures that matter, with a plain-English read. Full detail: HSIC · MCK

Updated 9 minutes ago

1-year performance, rebased to 100

HSIC +17.2%MCK +25.5%
McKesson edges it on the scoreable measures. McKesson has the highest Quant Rating (72); McKesson has done best over the past year (+26%); McKesson pays the highest dividend yield.
HSICMCK
Snapshot
SectorMedical Distribution--
Last price83.521,069.43
Change today-1.51%+0.68%
1-year return+17.3%+26.4%
Market cap$9.23B$123.47B
52-week range68.70 – 92.18722.11 – 1,121.50
Valuation
P/E (TTM)22.8827.48
P/E percentile, own 5-yr range71st73rd
P/B2.92-31.23
Dividend yield0.00%0.32%
Profitability & growth
EPS (TTM)3.2738.55
Net profit (TTM)$361.46M$4.45B
Revenue (TTM)$13.73B$418.79B
Provider revenue period date2026-09-252026-09-29
Revenue growth (YoY)+4.0%+7.6%
Gross margin31.6%3.7%
Operating margin5.8%1.7%
Net margin3.1%1.1%
Free cash flow (TTM)$500.00M$6.87B
Provider cash-flow period date2026-09-252026-09-29
Ownership & sentiment
Institutional ownership113.8%89.2%
Insider activity (12mo)25 buy / 22 sell21 buy / 27 sell
Short interest (% of float)8.4%1.7%
Analyst consensus60% buy / 30% hold / 10% sell (10)90% buy / 10% hold (10)
Analyst price target$97 (+16%)$1,211 (+13%)
StockVane view
StockVane Quant RatingC (63)C (72)
Company
Employees25,00043,000
Founded19321833

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.